The phase 3 clinical trial of CAN-2409 in intermediate-to-high-risk, localized prostate cancer met its primary endpoint, by demonstrating statistically significant improvement in disease-free survival ...
Investorideas.com, a leader in retail investor trading ideas for AI and tech stocks issues a news and trading alert for AmpliTech Group, Inc. (Nasdaq: AMPG) designer, developer, and manufacturer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback